Laboratorio Farmaceutico Erfo SpA (FRA:RK7) Total Liabilities : €1.82 Mil (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Laboratorio Farmaceutico Erfo SpA Total Liabilities?

Laboratorio Farmaceutico Erfo SpA's Total Liabilities for the quarter that ended in Dec. 2024 was €1.82 Mil.

Laboratorio Farmaceutico Erfo SpA's quarterly Total Liabilities declined from Dec. 2023 (€10.15 Mil) to Jun. 2024 (€2.35 Mil) and declined from Jun. 2024 (€2.35 Mil) to Dec. 2024 (€1.82 Mil).

Laboratorio Farmaceutico Erfo SpA's annual Total Liabilities declined from Dec. 2022 (€10.53 Mil) to Dec. 2023 (€10.15 Mil) and declined from Dec. 2023 (€10.15 Mil) to Dec. 2024 (€1.82 Mil).

Laboratorio Farmaceutico Erfo SpA Total Liabilities Historical Data

The historical data trend for Laboratorio Farmaceutico Erfo SpA's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorio Farmaceutico Erfo SpA Total Liabilities Chart

Laboratorio Farmaceutico Erfo SpA Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

1.48

2.21

10.53

10.15

1.82

Laboratorio Farmaceutico Erfo SpA Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Liabilities	Get a 7-Day Free Trial					10.53	2.47	10.15	2.35	1.82

Laboratorio Farmaceutico Erfo SpA Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Laboratorio Farmaceutico Erfo SpA's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.291	+	(0.242	+	1.6653345369377E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0.285	+	0)
	=	1.82

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	9.377	-	7.559
	=	1.82

Laboratorio Farmaceutico Erfo SpA's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.291	+	(0.242	+	1.6653345369377E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0.285	+	0)
	=	1.82

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	9.377	-	7.559
	=	1.82

Laboratorio Farmaceutico Erfo SpA Total Liabilities Related Terms

Thank you for viewing the detailed overview of Laboratorio Farmaceutico Erfo SpA's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Laboratorio Farmaceutico Erfo SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Laboratorio Farmaceutico Erfo SpA (FRA:RK7) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

ERFO:Italy

Address

Viale Geki Russo Lo. Pontegallo, Villafranca Tirrena, Messina, ITA, 98049

Website

https://www.erfo.it

Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.

Laboratorio Farmaceutico Erfo SpA Headlines

No Headlines